Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $6.4750 (5.63%) ($6.4750 - $6.4750) on Thu. Jan. 12, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.99% (three month average) | RSI | 59 | Latest Price | $6.4750(5.63%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 0.5% a day on average for past five trading days. | Weekly Trend | IOVA advances 2.6% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) XBI(51%) IBB(37%) IWC(31%) ARKG(29%) ACES(28%) | Factors Impacting IOVA price | IOVA will decline at least -2.495% in a week (0% probabilities). VIXM(-16%) UUP(-10%) USO(-8%) BND(-8%) EDOC(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.495% (StdDev 4.99%) | Hourly BBV | 2.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $6.25(3.6%) | 10 Day Moving Average | $6.28(3.11%) | 20 Day Moving Average | $6.2(4.44%) | To recent high | -33.5% | To recent low | 15.4% | Market Cap | $948m | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |